NO995831L - Klar injiserbar formulering av en anestetisk forbindelse - Google Patents

Klar injiserbar formulering av en anestetisk forbindelse

Info

Publication number
NO995831L
NO995831L NO995831A NO995831A NO995831L NO 995831 L NO995831 L NO 995831L NO 995831 A NO995831 A NO 995831A NO 995831 A NO995831 A NO 995831A NO 995831 L NO995831 L NO 995831L
Authority
NO
Norway
Prior art keywords
injectable formulation
anesthetic compound
clear
clear injectable
anesthetic
Prior art date
Application number
NO995831A
Other languages
English (en)
Norwegian (no)
Other versions
NO995831D0 (no
Inventor
Vincenzo Tommaso
Original Assignee
Westy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Westy Ag filed Critical Westy Ag
Publication of NO995831D0 publication Critical patent/NO995831D0/no
Publication of NO995831L publication Critical patent/NO995831L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO995831A 1997-05-26 1999-11-26 Klar injiserbar formulering av en anestetisk forbindelse NO995831L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH01224/97A CH692322A5 (it) 1997-05-26 1997-05-26 Formulazione iniettabile limpida di Propofol.
PCT/EP1998/003004 WO1998053805A1 (en) 1997-05-26 1998-05-14 Clear, injectable formulation of an anesthetic compound

Publications (2)

Publication Number Publication Date
NO995831D0 NO995831D0 (no) 1999-11-26
NO995831L true NO995831L (no) 2000-01-26

Family

ID=4205400

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995831A NO995831L (no) 1997-05-26 1999-11-26 Klar injiserbar formulering av en anestetisk forbindelse

Country Status (23)

Country Link
US (1) US6326406B1 (cs)
EP (1) EP0991405B1 (cs)
JP (1) JP2001527577A (cs)
KR (1) KR20010013011A (cs)
CN (1) CN1268051A (cs)
AR (1) AR012853A1 (cs)
AT (1) ATE230984T1 (cs)
AU (1) AU735020B2 (cs)
BR (1) BR9809492A (cs)
CA (1) CA2291261A1 (cs)
CH (1) CH692322A5 (cs)
DE (1) DE69810771D1 (cs)
DZ (1) DZ2503A1 (cs)
HU (1) HUP0002117A3 (cs)
IN (1) IN187550B (cs)
MY (1) MY132911A (cs)
NO (1) NO995831L (cs)
PA (1) PA8451701A1 (cs)
PE (1) PE75299A1 (cs)
PL (1) PL337026A1 (cs)
TR (1) TR200000116T2 (cs)
WO (1) WO1998053805A1 (cs)
ZA (1) ZA984314B (cs)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6749868B1 (en) 1993-02-22 2004-06-15 American Bioscience, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
CN1221249C (zh) 1998-08-19 2005-10-05 斯凯伊药品加拿大公司 普鲁泊福的可注射水分散体
WO2000044369A1 (en) * 1999-01-28 2000-08-03 Dinesh Shantilal Patel Parenteral solution of propofol (2,6-diisoprophylphenol) and 2.5- di- 0- methyl- 1.4;3.6- dianhydro- d- glucitol as a solvent
US6177477B1 (en) * 1999-03-24 2001-01-23 American Home Products Corporation Propofol formulation containing TRIS
US6635456B2 (en) * 2001-02-09 2003-10-21 Fidia Farmaceutici S.P.A. Procedure for the preparation of pure phosphatides with phospholipase D
US6803046B2 (en) * 2002-08-16 2004-10-12 Bracco International B.V. Sincalide formulations
KR100482269B1 (ko) * 2002-10-08 2005-04-14 센츄론(주) 2,6-디이소프로필페놀을 활성성분으로 하는 수용액상의마취용 주사제 및 그 제조방법
EP2359859A1 (en) * 2002-12-09 2011-08-24 Abraxis BioScience, LLC Compositions comprising albumin nanoparticles and methods of delivery of pharmacological agents
US20040225022A1 (en) * 2003-05-09 2004-11-11 Desai Neil P. Propofol formulation containing reduced oil and surfactants
US8476010B2 (en) 2003-07-10 2013-07-02 App Pharmaceuticals Llc Propofol formulations with non-reactive container closures
US8546453B2 (en) * 2003-08-14 2013-10-01 Rensheng Zhang Propofol compositions and methods for reducing pain associated with propofol injection
JP2005154305A (ja) * 2003-11-21 2005-06-16 Showa Yakuhin Kako Kk ヒアルロン酸含有組成物の製造方法
CN100358513C (zh) * 2005-04-07 2008-01-02 常州市第四制药厂有限公司 一种丙泊酚注射液的制备工艺
NZ566705A (en) 2005-08-31 2011-06-30 Abraxis Bioscience Llc Compositions and methods for preparation of poorly water soluble drugs with increased stability
JP5461837B2 (ja) 2005-08-31 2014-04-02 アブラクシス バイオサイエンス， エルエルシー 難水溶性医薬品および抗菌剤を含む組成物
JP2012509339A (ja) * 2008-11-20 2012-04-19 テイコク ファーマ ユーエスエー インコーポレーテッド ピラゾロン誘導体製剤
US11110063B2 (en) 2017-08-25 2021-09-07 MAIA Pharmaceuticals, Inc. Storage stable sincalide formulations
WO2019173526A1 (en) * 2018-03-07 2019-09-12 Andrew Xian Chen Aqueous formulations for insoluble drugs
JP7063217B2 (ja) * 2018-09-27 2022-05-09 住友電気工業株式会社 光ファイバの製造方法
JP7135670B2 (ja) * 2018-09-27 2022-09-13 住友電気工業株式会社 光ファイバ及び紫外線硬化型樹脂組成物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1089510B (de) * 1959-03-23 1960-09-22 Rudolf Reiss Dr Verfahren zur Herstellung waessriger, injizierbarer Loesungen von 2-Methoxy-4-allylphenoxyessigsaeure-N, N-Diaethylamid
US4798846A (en) * 1974-03-28 1989-01-17 Imperial Chemical Industries Plc Pharmaceutical compositions
GB1472793A (en) * 1974-03-28 1977-05-04 Ici Ltd Pharmaceutical compositions
DE3221579A1 (de) * 1982-06-08 1983-12-22 Eckert, Theodor, Prof. Dr., 4400 Münster Solubilisierung von in wasser schwerloeslichen wirkstoffen in waessrige loesung unter verwendung eines gemisches von cholinphosphorsaeureglycerindiester (cholin-lecithin) und natriumdesoxycholat als loesungsvermittler und die therapeutische verwendung der so erhaltenen waessrigen loesungen
CA1319886C (en) 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions
US5085864A (en) * 1989-10-30 1992-02-04 Abbott Laboratories Injectable formulation for lipophilic drugs
DE4039602A1 (de) * 1990-12-12 1992-06-17 Bauer Kurt Heinz Prof Dr Pharmazeutische formulierungen
GB9405593D0 (en) 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
ZA962214B (en) 1995-04-10 1996-10-07 Farmarc Nederland Bv Pharmaceutical composition
AU6708096A (en) 1995-09-18 1997-04-09 Vesifact Ag Propofol nanodispersions
US5637625A (en) * 1996-03-19 1997-06-10 Research Triangle Pharmaceuticals Ltd. Propofol microdroplet formulations

Also Published As

Publication number Publication date
IN187550B (cs) 2002-05-18
ZA984314B (en) 1998-12-08
DE69810771D1 (de) 2003-02-20
PL337026A1 (en) 2000-07-31
PE75299A1 (es) 1999-08-26
DZ2503A1 (fr) 2005-01-25
US6326406B1 (en) 2001-12-04
PA8451701A1 (es) 2000-05-24
EP0991405A1 (en) 2000-04-12
CA2291261A1 (en) 1998-12-03
TR200000116T2 (tr) 2000-05-22
HUP0002117A2 (hu) 2000-12-28
BR9809492A (pt) 2000-06-20
NO995831D0 (no) 1999-11-26
HUP0002117A3 (en) 2001-04-28
JP2001527577A (ja) 2001-12-25
AR012853A1 (es) 2000-11-22
AU735020B2 (en) 2001-06-28
ATE230984T1 (de) 2003-02-15
KR20010013011A (ko) 2001-02-26
MY132911A (en) 2007-10-31
CH692322A5 (it) 2002-05-15
AU8209798A (en) 1998-12-30
CN1268051A (zh) 2000-09-27
WO1998053805A1 (en) 1998-12-03
EP0991405B1 (en) 2003-01-15

Similar Documents

Publication Publication Date Title
NO995831L (no) Klar injiserbar formulering av en anestetisk forbindelse
NO952357D0 (no) Formulering av insulinanaloger
BR9500784A (pt) Composto e formulação farmacêutica
ATE263147T1 (de) Derivate von aryloxyarylsulfonylamino hydroxyaminsäuren
ID24372A (id) SENYAWA-SENYAWA 4-AMINO-TIAZOL-2-IL SEBAGAI PENGHAMBAT-PENGHAMBAT CDKs
DE69815099D1 (de) Kosmetische zusammensetzungen
FI972292A0 (fi) Administrering av diabetes
PT925083E (pt) Seringas
PT892640E (pt) Composicoes farmaceuticas de micofenolato entericamente revestidas
DE69634256D1 (de) Zementformulierung
BR1100329A (pt) Composto e formulação farmacêutica
PT868183E (pt) Formulacoes injectaveis de quinolona
IT1304793B1 (it) Miscela di stabilizzanti
NO995251D0 (no) FremgangsmÕte for administrering av haloterapi
DE69812588D1 (de) Medizinischer injektor
BR9707808A (pt) Composto composição farmacêutica e uso do composto
IT1304794B1 (it) Miscela di stabilizzanti
ID18832A (id) Komposisi insektisida
NO20003105L (no) Fenylaminoalkylkarboksylsyre-derivater samt medisinske sammensetninger omfattende slike
BR9612413A (pt) Composto uso do mesmo e composição farmacêutica
ID24677A (id) Kombinasi senyawa aktif fungisidal
DE69835595D1 (de) Kosmetische zusammensetzungen enthaltend smektitgele
DE69824956D1 (de) Versprühbare gelierte zusammensetzung
ATE378327T1 (de) Substituierte cyclobutylaminderivate
IT1293320B1 (it) Miscela di stabilizzanti

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application